Amneal Pharmaceuticals Inc (AMRX)
6.12
+0.07
(+1.16%)
USD |
NASDAQ |
May 01, 16:00
6.11
-0.01
(-0.16%)
After-Hours: 17:45
Amneal Pharmaceuticals Total Liabilities (Quarterly): 3.453B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.453B |
| September 30, 2023 | 3.496B |
| June 30, 2023 | 3.518B |
| March 31, 2023 | 3.464B |
| December 31, 2022 | 3.615B |
| September 30, 2022 | 3.657B |
| June 30, 2022 | 3.851B |
| March 31, 2022 | 3.482B |
| December 31, 2021 | 3.573B |
| September 30, 2021 | 3.591B |
| June 30, 2021 | 3.633B |
| March 31, 2021 | 3.593B |
| Date | Value |
|---|---|
| December 31, 2020 | 3.661B |
| September 30, 2020 | 3.689B |
| June 30, 2020 | 3.686B |
| March 31, 2020 | 3.987B |
| December 31, 2019 | 3.319B |
| September 30, 2019 | 3.308B |
| June 30, 2019 | 3.513B |
| March 31, 2019 | 3.585B |
| December 31, 2018 | 3.456B |
| September 30, 2018 | 3.667B |
| June 30, 2018 | 3.605B |
| December 31, 2017 | 1.717B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.308B
Minimum
Sep 2019
3.987B
Maximum
Mar 2020
3.584B
Average
3.591B
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Fate Therapeutics Inc | 137.80M |
| Ocular Therapeutix Inc | 160.93M |
| Editas Medicine Inc | 150.06M |
| AnaptysBio Inc | 364.29M |
| Stoke Therapeutics Inc | 68.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.473B |
| Shareholders Equity (Quarterly) | 19.78M |
| Debt to Equity Ratio | 133.49 |
| Current Ratio | 1.628 |
| Net Debt Paydown Yield | 1.03% |